Evaluate for an enlarged spleen or splenic rupture in patients who report left upper abdominal or shoulder pain after receiving ZIEXTENZO.Īcute Respiratory Distress Syndrome (ARDS)

Splenic rupture, including fatal cases, can occur following the administration of pegfilgrastim.

ZIEXTENZO is contraindicated in patients with a history of serious allergic reactions to pegfilgrastim or filgrastim.

IMPORTANT SAFETY INFORMATION FOR ZIEXTENZO CONTRAINDICATIONS Therapeutic, prophylactic, or diagnostic injection (specify substance or drug) subcutaneous or intramuscular Primary and secondary diagnosis codes may be requiredĬPT codes describe the therapeutic injection or infusion. Report the appropriate diagnosis code(s) to describe the patient's condition. Pack of 1 sterile 6 mg/0.6 mL prefilled syringeĪllowable diagnosis codes vary by payer. Injection: clear, colorless to slightly yellowish solution supplied in a single-dose prefilled syringe for manual use containing 6 mg pegfilgrastim, supplied with a 27-gauge, 1/2-inch needle with an BD™ UltraSafe Passive ® Needle Guard 1

Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo) 0.5 mg For reimbursement information, please contact Sandoz One Source. Verify payer-specific coding requirements.

Icd 10 code for hematuria